“Dormant” Drug Candidates Eligible For Exclusivity Incentives In Draft Bill
Executive Summary
Biopharmaceutical companies would be offered data exclusivity incentives to develop “dormant” drug candidates for unmet medical needs under draft legislation being floated in the House by the National Health Council patient advocacy organization.